Dramatic advances in understanding the genetic basis for cancer have led to new technologies and tools for genetic cancer risk assessment. Recognizing the exceptional potential of this emerging discipline, the director of the National Cancer Institute has described the field of cancer genetics as an """"""""Extraordinary Opportunity for Investment"""""""". Yet cancer is a complex disorder, and there are barriers to the efficient identification and management of patients and families at high risk. These include a shortage of health care professionals who are qualified to carry out research on cancer prevention within the context of the complex medical, technological, psychological and ethical issues associated with cancer risk counseling and genetic testing. Accurate risk assessment is a critical component of cancer prevention and control activities and is emerging as a new field of study, incorporating established empiric risk models and rapidly-evolving genetic technologies for estimating individual cancer risk. There are no formal multidisciplinary clinical cancer genetics research training programs, so clinicians and researchers typically developed their skills through on-the-job experience. The goal of the City of Hope (COH) Clinical Cancer Genetics Fellowship Program, endorsed by the American Society of Clinical Oncology Training Program Committee, is to train research program leaders and team members from physician fellows, oncology nurses and genetic counselors through innovative interdisciplinary training focused on cancer prevention and control research, with experience providing insight into the critical translational issues in cancer risk assessment, genetic counseling, and cancer risk management. Fellows will complete a rigorous program of broad-spectrum didactic training in oncology, genetics and research methodology, a cross-disciplinary cancer genetics research project, and closely mentored clinical training. Graduates will receive a specialty program Certificate after one year. Doctoral fellows will devote a second year to additional research training and coursework, culminating in a Masters Degree in Applied Cancer Genetics. The COH and Beckman Research Institute has a long history of multidisciplinary training and cutting edge basic and clinical research in cancer genetics, molecular biology, protein chemistry, immunology, bone marrow transplantation, molecular genetics and experimental therapeutics. The Department of Clinical Cancer Genetics and its Cancer Screening & Prevention Program have gained wide recognition for excellence in clinical cancer genetics services, cancer genetics education, cancer prevention and control trials and genetic epidemiological research. The clinical program serves families in greater Los Angeles through a network of satellite clinics, providing an ideal opportunity for experiential training. The clinical and translational research strength of the Cancer Screening & Prevention Program and integrated collaboration with existing multidisciplinary COH educational and research efforts offers a robust environment for the proposed program. This Fellowship Program will successfully further the national effort to incorporate the rapidly expanding field of cancer genetics into cancer prevention and control research.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Education Projects (R25)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-GRB-N (V2))
Program Officer
Myrick, Dorkina C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
City of Hope/Beckman Research Institute
United States
Zip Code
Obregon-Tito, Alexandra J; Tito, Raul Y; Metcalf, Jessica et al. (2015) Subsistence strategies in traditional societies distinguish gut microbiomes. Nat Commun 6:6505
Weitzel, Jeffrey N; Clague, Jessica; Martir-Negron, Arelis et al. (2013) Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol 31:210-6
Culver, J O; Brinkerhoff, C D; Clague, J et al. (2013) Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress. Clin Genet 84:464-72
Sorrell, April D; Espenschied, Carin R; Culver, Julie O et al. (2013) Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions. Mol Diagn Ther 17:31-47
Blazer, Kathleen R; Christie, Christina; Uman, Gwen et al. (2012) Impact of web-based case conferencing on cancer genetics training outcomes for community-based clinicians. J Cancer Educ 27:217-25
Sorrell, A; Espenschied, C; Wang, W et al. (2012) Hereditary leukemia due to rare RUNX1c splice variant (L472X) presents with eczematous phenotype. Int J Clin Med 3:
Newhauser, Wayne D; Scheurer, Michael E; Faupel-Badger, Jessica M et al. (2012) The future workforce in cancer prevention: advancing discovery, research, and technology. J Cancer Educ 27:S128-35
Beamer, Laura C; Grant, Marcia L; Espenschied, Carin R et al. (2012) Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol 30:1058-63
Clague, Jessica; Wilhoite, Greg; Adamson, Aaron et al. (2011) RAD51C germline mutations in breast and ovarian cancer cases from high-risk families. PLoS One 6:e25632
Lagos-Jaramillo, Veronica I; Press, Michael F; Ricker, Charite N et al. (2011) Pathological characteristics of BRCA-associated breast cancers in Hispanics. Breast Cancer Res Treat 130:281-9

Showing the most recent 10 out of 26 publications